chrisvoncsefalvay/vaers-outcomes huggingface dataset:
16 year old grand son received the first Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old grand son received the first Moderna vaccine) in a 16-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old grand son received the first Moderna vaccine). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (16 year old grand son received the first Moderna vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment details were provided.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Additional information received and Patient demographics added. On 29-Jul-2021: Follow up received and contains no new information. On 29-Jul-2021: Follow up received and contain non significant information. On 04-Aug-2021: Follow up received and contains Non significant information.
Patient received Janssen COVID-19 vaccination at 1013.  At 1035 patient reported difficulty swallowing and a mild red rash was noted to patient's neck.  Vital signs stable. Patient denied dyspnea, N/V, dizziness and itch.  MD notified.  BP 133/86, HR 75, RR 18, SpO2 97%.  ***     ***   At 1057 patient reported feeling hot, scant sweating noted to back, itch to throat continued, scant swelling noted to both hands and patient reported "shoes feeling tighter". Rash no longer noted to patient's neck.  Dyspnea denied.  ***     ***   At 1115 MD ordered 25mg IM diphenhydramine one time as needed for throat itch.  Administered to left deltoid.  MD ordered for patient to be observed for an additional 30 minutes.  ***     ***   At 1120 patient stated relief from throat itch and difficulty swallowing.  ***     ***   Patient left clinic in stable condition at 1148. BP 121/83, HR 75, RR 18, SpO2 98% RA.  Denied dyspnea, N/V, itch, rash, swelling, dizziness upon leaving.  ***
nose is running; back of throat is itching; coughing a lot; eyes are burning; This is a spontaneous report from a contactable consumer (patient). A 59-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration, administered on the left arm on 25Mar2021 08:00 (Lot Number: NE6208) (at the age of 59 years old) as dose 1, single for COVID-19 immunisation. The vaccine was administered in a Hospital facility. The patient's medical history included ongoing high blood pressure (diagnosed 10 or 12 years ago) and surgery (had surgery ten years ago). The patient takes his normal medications every day. On 26Mar2021, the patient experienced nose is running, back of throat is itching, coughing a lot, and eyes are burning. The patient stated that his "nose is running" has dried up now, but in a little bit, it'll start running again soon. The patient underwent lab tests and procedures which included an x-ray of his chest: unknown result on an unspecified date. The patient started taking dextromethorphan hydrobromide;doxylamine succinate;ephedrine sulfate;ethanol;paracetamol (NYQUIL), paracetamol (TYLENOL), guaifenesin (ROBITUSSIN), eucalyptus globulus oil;menthol (HALLS), and hot tea but the events keep on persisting. The patient has not recovered from the events.  No follow-up attempts are possible. No further information is expected.
no further AE; MMR administration not completed; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender.  The patient's medical history was not reported. The patient's concurrent conditions were not reported. Concomitant therapies were not reported.  On 18-AUG-2023, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection, one time, administered for prophylaxis (strength, dose, lot #, expiry date, and route of administration were not provided). Measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) administration was not completed. The patient turned during administration and "drops" of the vaccine fell on the "surface" (incorrect dose administered).  It was unable to specify how much of the vaccine was actually administered. No further adverse event was reported.
In about 12-14 hours after the 2nd dose of the Pfizer/BioNTech vaccine developed sever fever, chills, violent shivering. In about 24-26 hours after the vaccination chest pain/discomfort/pressure started, predominantly on the left side, and continued on and off with moderate severity until the end of June, the pain started to subside as of Jul 1, 2021.
I started getting upset stomach around 6pm - cramps and diarrhea. That continued until about 10:30pm. I then went to bed and woke up about 1:30am with chills & shaking - I could not get warm but had a fever. I then started again with diarrhea and vomiting also started. This lasted until about 3:30am. Throughout this, I had a headache and body aches as well which went well into Saturday during the day.
Mother brought child in for kindergarten registration. Mother presented shot record to clerical staff to record on green card. Only 1 Varicella was documented on green card and mother was offered 3rd Varicella per protocol. Shot record was given back to mother. Child was given Varicella then mother presented shot record to nurse after shot was given. 2 Varicella's were documented on patient's shot record. This was 3rd Varicella. Mother instructed on symptoms to watch for and call with any problems. 8-8-07 Called mother to check on patient. States that patient has no symptoms other than  mild local reaction.
Fever/temperature was 99.6/ 99.4 /99.3; This is a spontaneous report from a contactable consumer. A 78-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) dose 2 via an unspecified route of administration on 25Mar2021 09:00 (Batch/Lot Number: ER8732; Expiration Date: 31Jul2021) as single dose for covid-19 immunisation. Medical history included heart valve replacement from 13Nov2019 to an unknown date (His heart operation was 13Nov2019 it has been 16 months that he has been inactive), chronic myeloid leukaemia from 2018 to an unknown date, accumulating fluid around the lung sack from an unknown date and unknown if ongoing aortic stenosis (from an unknown date and unknown if ongoing (They changed the heart valve because he had aortal stenosis), heart murmur from an unknown date and unknown if ongoing (He went in to see his general practitioner and a woman there said he had a heart murmur) cough from an unknown date and unknown if ongoing (Caller states he has a little cough. He quit smoking several years ago and has been coughing ever since. The cough was prior to COVID-19 vaccines) fell from Nov2020 to an unknown date (Caller fell the first week of Nov2020 and that is how long the process has taken. He has been in pain for months. Caller clarified that his hospitalizations and fall were prior to getting the vaccine). The patient previously took first dose of bnt162b2 for covid-19 immunisation and sprycel and experienced kidneys were failing. (Caller clarified that the hospitalization he had for 8 days was when he was on Sprycel and he was hospitalized because his kidneys were failing). Caller clarified that he has a fever, but he is not sure what it is because of the thermometer. Earlier today it was 99.6. It is now 2:24PM (State name) time, so it has been 5.5 hours since the vaccine on 25Mar2021. His temperature was 99.6 then 99.4 then 99.3. Frankly he doesn't trust it. He had positive experience both times he got the COVID Vaccine. The patient underwent lab tests and procedures which included body temperature: 99.6 on 25Mar2021 body temperature: 99.4 on 25Mar2021 body temperature: 99.3 on 25Mar2021 white blood cell count: unknown results on (When he went to the doctor to get checked he had unusual white blood cells running). The outcome of the event was reported as unknown.   No follow up attempts are needed. No further information is expected.
ELEVATED CLOT LEVELS; DIZINESS/LIGHTHEADED; NAUSEA; BRUISE ON LEG; SWELLING; WISDOM TOOTH PULLED; This spontaneous report was received from a consumer and concerned a female of unspecified age and sex. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of administration not reported, batch number and expiration date: Unknown) dose was not reported,1 total administered on 11-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. The patient's father reported that on 06-Apr-2021, in urgent care patient's wisdom tooth was pulled.  On 08-APR-2021, the subject experienced diziness/lightheaded, nausea, bruise on leg, swelling  4x4 inches on lower right calf. The next day, the patient's bruise/swelling move to inside of right knee, she had new bruise on leg and went to urgent care; the doctor told her she hit it. On 09-APR-2021, the bruise moved to inside of knee, and the patient was taken to emergency room (ER) where "clot test" showed elevated clot levels and rivaroxaban (Xarelto) was prescribed for treatment. On 10-APR-2021 (Saturday morning), ultrasound was done; result not reported. At the time of report  there was decreased in swelling. The patient's father stated that, the event's might be related to wisdom tooth pulled. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from elevated clot levels, diziness/lightheaded, nausea, bruise on leg, and swelling. This report was serious (Other Medically Important Condition).; Sender's Comments: V0: This is a female patient, unspecified age, unspecified ethnicity, who experienced elevated clot levels 29 days after receiving the Janssen COVID-19 vaccine and 3 days after the patient's wisdom tooth was pulled out.  The patient had her wisdom tooth pulled out 26th day post vaccination. 2 days later (28 days after the vaccination), the patient experienced dizziness and nausea and was noted to have bruise and swelling (around 4x4 inches) on the right lower leg. The next day, bruise/swelling was noted to reach the area of the right knee, probably the medial side, which prompted consult at the ER. The "clot test"  done as was noted to be elevated (no actual results provided). An ultrasound was also done but the result was not reported. Long periods of immobility (sitting in the dental chair) and the temporal plausibility from the dental procedure to the event of elevated clot levels confounds the temporal plausibility of the elevation of clot level and the vaccine; hence this is assessed as indeterminate per classification of adverse event following immunization. Additional information requested.
Extreme diarrhea that commenced 8 hours after injection. OTC antidiarrheal treatments were not effective. Explosive and liquid diarrhea episodes every 4-6 hours.   No appetite and abdominal aches.
Fainting,pain,itching,fatigue,headache,nausea, Lost of smell, short term memory off and on,; Fainting,pain,itching,fatigue,headache,nausea, Lost of smell, short term memory off and on,; Fainting,pain,itching,fatigue,headache,nausea, Lost of smell, short term memory off and on,; Fainting,pain,itching,fatigue,headache,nausea, Lost of smell, short term memory off and on,; Fainting,pain,itching,fatigue,headache,nausea, Lost of smell, short term memory off and on,; Fainting,pain,itching,fatigue,headache,nausea, Lost of smell, short term memory off and on,; Fainting,pain,itching,fatigue,headache,nausea, Lost of smell, short term memory off and on,; Fainting,pain,itching,fatigue,headache,nausea, Lost of smell, short term memory off and on,; This is a spontaneous report from a contactable consumer (patient). A 65-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 29Apr2021 12:45 PM at the age of 65-years-old (Batch/Lot Number: Unknown) as 1ST DOSE, SINGLE for covid-19 immunisation.  Medical history included Herniated discs L4,L5,S1,C4,C5C6C7, type 2 diabetes from an unknown date. Concomitant medications included apixaban (ELIQUIS); dipyridamole (METROPOLYN) and bupropion, all taken for an unspecified indication, start and stop date were not reported.  The patient previously took lidocaine and experienced allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.  On 29Apr2021 01:15 PM, the patient experienced Fainting, pain, itching, fatigue, headache, nausea, Lost of smell, short term memory off and on. It was unknown if treatment received. The outcome of the events was resolving.   Information on the lot/batch number has been requested.
7:00 started chills 9:00 started fever 101.8/chills/fatigue 10:00 fever 103.2 /chills/ fatigue/ headache/ nausea / crazy sweats continues until Monday Morning  of the 12th fever drops to 101. 8 Diarrhea  started Sunday stays that way until Monday after noon . Puking starts and diarrhea continues until Weds.  Headache gets milder everyday still need aspirin to keep under control. Sweats are still happening.  Went to hospital Tuesday because my legs felt like lead. High BP
Pt developed atypical varicella lesions on body and arm fourteen days after exposure to chickenpox.
Vaccination given at 5:45 pm. 5:50 pm, patient reported feeling her throat tighten and heart racing. Felt the shot go through her system. Skin: pale, diaphoretic, BP with small cuff left arm was 157/101; pulse oximeter 100%; HR 71 auscultation. Reported having cream cheese and water before shot. Feet elevated; ice pack to forehead; offered water and able to swallow easily. 6 pm:  BP 140/98; skin now flushed; pulse oximeter 99%; HR 71; needed reading with larger cuff; called 911. EMS arrived at 6:05 pm; BP with large cuff 145/83 taken to ER. Director notified of event and will call patient later for status.
This spontaneous report was received from a consumer refers to a 14 year old female patient. The patient's concurrent conditions included attention deficit/hyperactivity disorder, anxiety and depression. The patient's medical history and historical drugs were not reported. The patient's concomitant medications included ADDERALL and LEXAPRO. On an unknown date in October 2017, the patient was vaccinated with the first dose in the HPV vaccination series with GARDASIL or GARDASIL 9 intramuscularly for prevention of cervical cancer. The patient reported that the patient started having symptoms of cellulitis on 31-JAN-2018. It was unspecified where the cellulitis was located on the patient's body. The patient reported that the patient was hospitalized for cellulitis on 02-FEB-2018 and was still in the hospital. The patient also reported that on an unspecified date between 02-FEB-2018 and 05-FEB-2018, while hospitalized, the patient was diagnosed with "the flu." The patient underwent lab diagnostics: complete blood count and extensive blood tests: results were not provided. The patient received unspecified treatment for the events, on an unknown date. The outcome of events, cellulitis and influenza was reported as not recovered. The relationship between events and GARDASIL or GARDASIL 9 was not provided. No product quality complaint was involved. The patient had significant disability or incapacity and missed the school due to the events. Upon internal review, the event cellulitis was determined to be medically significant and also considered serious due to hospitalization.
At 10 minutes after vaccine patient stated lips were tingling - stated that happens a lot. At 30 minutes post injection (1040 am), patient began having tight throat, hoarseness, and cough. Pt self administered Xopenex 2 puffs, Nasal O2 started at 3L (Sp02 98% on 3L) and EpiPen used x1 in left thigh. EMS arrived at 1045. Patient transported to ED at 1102.
initially with redness and itching on chest and neck, elevated BP to 190/100, but otherwise normal 02 , HR, RR. Symptoms developed within 20 ish minutes of receiving vaccine. Hives developed on neck and near ear, then patient reported perioral sensations. Patient was non-verbal and communicating using texting so communication was challenging. Patient was initially given benadryl, but with the additional perioral sensations Epi was given. Patient transported to ER via rapid response team where additional benadryl and steriods were given.
Patient tested positive for COVID following completion of the 2 dose series; Patient tested positive for COVID following completion of the 2 dose series; This is a spontaneous report from a non-contactable consumer or other non-health care professional. A 59-year-old male patient received first dose of bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: FC3180) via an unspecified route of administration, on 05Aug2021 (at the age at vaccination of 59-year-old) as dose 1, single; second dose of bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: FC3180) via an unspecified route of administration, on 26Aug2021 (at the age at vaccination of 59-year-old) as dose 2, single both doses for covid-19 immunization at unknown vaccine facility. The patient's medical history and concomitant medications were not reported. On 18Oct2021, patient tested positive for COVID following completion of the 2 dose series. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 18Oct2021. Outcome of the events was unknown.  No follow up attempts are possible. No further information is expected.
Chills on night of administration; flu-like aches and lethargy the entire next day; red blotch at injection site on left arm where pneumonia shot administered with sore muscle; red blotch at injection site on right arm where shingles shot administered with sore muscles. Symptoms persist from Friday until Monday at time of reporting.
PT RECIEVED VACCINE IN CLINIC CALLED 2 DAYS LATER STATING ARM WAS RED AND SWOLLEN AND NOT GOING AWAY.
Post vax, the pt developed cellulitis that went down to the wrist. The pt sought unspecified medical attention.
102 temp after second shot; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (102 temp after second shot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (102 temp after second shot). At the time of the report, PYREXIA (102 temp after second shot) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 (High) 102.         Reportedly, the patient declined for follow-up.  Concomitant product use was not provided.  Treatment product information was not provided.
had a pain on her left side lung that "hit her like a knife."/sharp pain in left lung where histoplasmosis is; head cold and sneezing; head cold and sneezing; arm a little sore; This is a spontaneous report from a contactable nurse (patient). An 80-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EM9809), via an unspecified route of administration, administered in left arm on 12Feb2021 10:30 as single dose for COVID-19 immunisation. The patient's medical history included histoplasmosis in left lung, diagnosed 15-20 years ago, asthma in the past and has taken before Advair or Ventolin but has not had to take that in over a year. The patient's concomitant medications were not reported. The patient previously took articaine and had a reaction. The patient also previously received a Tetanus shot in the past, got a hot arm and a little fever. She got the Pfizer vaccine on 12Feb2021, and stated that day her arm was a little bit sore. On Sunday morning (14Feb2021) when she woke up, she had a head cold and sneezing lots of tickling in her nose. She stated that she had no sore throat, no fever, and stated that lasted until this morning. The patient reported that last night she went to bed and had a pain on her left side lung that hit her like a knife on 16Feb2021. The pain continued throughout the night and it really hurt, really shocked her. She couldn't lay on that side. She had a sharp pain in left lung where histoplasmosis is. The vaccination facility type was clinic. Vaccine was not administered in military facility. The patient is scheduled to receive the second dose on 06Mar2021. The outcome of the event had a pain on her left side lung that "hit her like a knife"/sharp pain in left lung where histoplasmosis is was recovering; the outcome of the events head cold and sneezing was recovered on 17Feb2021; and the outcome of the event arm a little sore was unknown.  Follow-up attempts are completed. No further information is expected.
The patient called one day after vaccine administration and described the injection site as being red, hot, quarter sized, and painful. She called again three days after vaccination and described the injection site as being red, hot, and softball size. She states that the pain at the injection site had decreased from our previous conversation.
Patient complains of immediate onset of symptoms following dose two of Moderna injections. Vomitting, severe headache, bodyaches fever and rash at injection site. Symptoms have progressed at 3 weeks following injections- worsening of bodyaches, now severe joint pains, off balance, vertigo, confusion and difficulty concentrating, shortness of breath, extreme fatigue, nausea- unable to eat, headache is persistant and unrelieved by medication, left sided body weakness/numbness, rash is now on upper and lower extremities
8OCT92 pt recvd DTP/OPV/HIB/Hep B vax & approx 3 hrs later began crying constantly for 6 hrs, irritable, fever to 103 that noc;
This is an instance of breakthrough COVID-19 after which death occurred. The individual was vaccinated with the Moderna product on 01/01/2021 and 01/27/2021. They first tested positive on 08/26/2021 at the nursing home at which they were a resident. Two additional tests collected on 08/26/2021 were also positive. A repeat test on 08/30/2021 was negative, however. The individual died on 09/08/2021. COVID-19 is listed in Part II of the death certificate. I see no evidence that the individual was hospitalized related to this illness.
This spontaneous report was received from a nurse concerning an unspecified number of patients (demographics unknown). The patients' pertinent medical history and concurrent conditions were not provided. On unspecified dates, the patients received an improperly stored dose of M-M-R II (Lot # L004656; expiration date: 11-FEB-2017) (dose and route not provided). Concomitant therapies were not provided. No adverse effect was reported. It was reported the following temperature excursion for the administered vaccines: 50 F for 4 hours and 6 minutes. No previous temperature excursion was reported. This is one of two reports received from the same source. Additional information has been requested.